EPA (Eicosapentaenoic Acid)

EPA (eicosapentaenoic acid) is an omega-3 fatty acid that produces anti-inflammatory eicosanoids like resolvins and protectins. It reduces cardiovascular disease risk by lowering triglycerides and decreasing inflammatory markers like C-reactive protein.

Origin & History

EPA is a long-chain omega-3 fatty acid primarily found in cold-water fish such as salmon, mackerel, and sardines. It is extracted through processes like molecular distillation to ensure purity and concentration.

Historical & Cultural Context

Traditionally consumed in high amounts by indigenous Arctic populations, EPA-rich fish oils have been used for centuries for their health benefits. Modern science has validated many traditional claims.

Health Benefits

- Supports cardiovascular health by reducing triglyceride levels, lowering the risk of heart disease. Studies show a 25% reduction in triglycerides. - Reduces inflammation, which may alleviate symptoms of chronic inflammatory conditions. This leads to improved joint and muscle health. - Enhances mood and mental health by modulating serotonin levels, promoting emotional well-being. This can result in a 20% decrease in depression symptoms. - Supports brain health by improving blood flow to the brain, enhancing cognitive function. This can lead to better focus and mental clarity. - Promotes skin health by reducing inflammation and improving skin barrier function. This results in a 30% improvement in skin texture. - Aids in weight management by promoting fat oxidation, enhancing metabolic rate. This supports healthy weight loss and maintenance. - Boosts immune function by enhancing the activity of white blood cells, strengthening the body's defense mechanisms. This reduces the risk of infections.

How It Works

EPA competes with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, reducing pro-inflammatory prostaglandins and leukotrienes. It generates specialized pro-resolving mediators including E-series resolvins and protectins that actively resolve inflammation. EPA also inhibits NF-κB signaling and reduces production of inflammatory cytokines like TNF-α and IL-6.

Scientific Research

Numerous RCTs support EPA's role in reducing triglycerides and inflammation. Meta-analyses confirm its cardiovascular benefits, though more research is needed on mood disorders.

Clinical Summary

Meta-analyses of randomized controlled trials demonstrate EPA supplementation reduces triglycerides by 15-30% at doses of 2-4g daily. The REDUCE-IT trial (n=8,179) showed 2g twice-daily EPA reduced cardiovascular events by 25% over 4.9 years. Systematic reviews indicate EPA doses of 1.8-2.7g daily significantly reduce inflammatory markers including C-reactive protein. Evidence is strongest for cardiovascular benefits, with moderate evidence for anti-inflammatory effects in rheumatoid arthritis.

Nutritional Profile

- Contains 20 carbon atoms and 5 double bonds.
- Typically found in concentrations of 180 mg per 1000 mg fish oil capsule.
- Provides approximately 9 calories per gram.

Preparation & Dosage

Typical dosage ranges from 500 mg to 2000 mg per day, often combined with DHA. Consult a healthcare provider before use.

Synergy & Pairings

DHA,ALA,GLA,Vitamin D,Astaxanthin

Safety & Interactions

EPA is generally well-tolerated with mild gastrointestinal side effects including nausea and fishy aftertaste reported in some users. High doses above 3g daily may increase bleeding risk and interact with anticoagulant medications like warfarin. EPA can enhance the effects of blood pressure medications, potentially causing hypotension. Pregnancy safety data is limited, though moderate omega-3 intake is considered beneficial during pregnancy.